A high level of STAT5 was observed in CML patients in disease progression to advanced stage and a positive correlation between STAT5 expression and the occurrence of mutations in the BCR-ABL1 gene was observed [15]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.